Pharmacokinetic/Pharmacodynamic Profile of Voriconazole

Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever

Thomas J. Walsh, Peter G. Pappas, Drew J. Winston et al. · New England Journal of Medicine · 2002 · 986 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Pharmacokinetics and Safety of Voriconazole following Intravenous- to Oral-Dose Escalation Regimens

Lynn Purkins, Nolan Wood, Parviz Ghahramani et al. · Antimicrobial Agents and Chemotherapy · 2002 · 413 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +13

Antifungal Activities of Posaconazole, Ravuconazole, and Voriconazole Compared to Those of Itraconazole and Amphotericin B against 239 Clinical Isolates of <i>Aspergillus</i> spp. and Other Filamentous Fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000

Michael A. Pfaller, S. A. Messer, R. J. Hollis et al. · Antimicrobial Agents and Chemotherapy · 2002 · 402 citations · Full text

Medicine, Microbiology, Pharmacology +17

Identification of the Cytochrome P450 Enzymes Involved in the N-Oxidation of Voriconazole

Ruth Hyland, B. C. Jones, Dennis A. Smith · Drug Metabolism and Disposition · 2003 · 381 citations

Medicine, Biochemistry, Pharmacology +17

Activities of Caspofungin, Itraconazole, Posaconazole, Ravuconazole, Voriconazole, and Amphotericin B against 448 Recent Clinical Isolates of Filamentous Fungi

Daniel J. Diekema, S. A. Messer, R. J. Hollis et al. · Journal of Clinical Microbiology · 2003 · 371 citations · Full text

Life Sciences, Microbiology, Pharmacology +15